Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 2
2005 2
2006 5
2007 2
2008 1
2009 3
2010 5
2011 6
2012 3
2013 1
2014 6
2015 6
2016 5
2017 2
2018 4
2019 9
2020 8
2021 9
2022 10
2023 7
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

86 results

Results by year

Filters applied: . Clear all
Page 1
Radiolabeled Bombesin Analogs.
Mansi R, Nock BA, Dalm SU, Busstra MB, van Weerden WM, Maina T. Mansi R, et al. Among authors: van weerden wm. Cancers (Basel). 2021 Nov 17;13(22):5766. doi: 10.3390/cancers13225766. Cancers (Basel). 2021. PMID: 34830920 Free PMC article. Review.
Extensive preclinical evaluation of lutetium-177-labeled PSMA-specific tracers for prostate cancer radionuclide therapy.
Ruigrok EAM, van Vliet N, Dalm SU, de Blois E, van Gent DC, Haeck J, de Ridder C, Stuurman D, Konijnenberg MW, van Weerden WM, de Jong M, Nonnekens J. Ruigrok EAM, et al. Among authors: van weerden wm. Eur J Nucl Med Mol Imaging. 2021 May;48(5):1339-1350. doi: 10.1007/s00259-020-05057-6. Epub 2020 Oct 23. Eur J Nucl Med Mol Imaging. 2021. PMID: 33094433 Free PMC article.
The future of patient-derived xenografts in prostate cancer research.
Lawrence MG, Taylor RA, Cuffe GB, Ang LS, Clark AK, Goode DL, Porter LH, Le Magnen C, Navone NM, Schalken JA, Wang Y, van Weerden WM, Corey E, Isaacs JT, Nelson PS, Risbridger GP. Lawrence MG, et al. Among authors: van weerden wm. Nat Rev Urol. 2023 Jun;20(6):371-384. doi: 10.1038/s41585-022-00706-x. Epub 2023 Jan 17. Nat Rev Urol. 2023. PMID: 36650259 Free PMC article. Review.
In vitro dose effect relationships of actinium-225- and lutetium-177-labeled PSMA-I&T.
Ruigrok EAM, Tamborino G, de Blois E, Roobol SJ, Verkaik N, De Saint-Hubert M, Konijnenberg MW, van Weerden WM, de Jong M, Nonnekens J. Ruigrok EAM, et al. Among authors: van weerden wm. Eur J Nucl Med Mol Imaging. 2022 Sep;49(11):3627-3638. doi: 10.1007/s00259-022-05821-w. Epub 2022 May 12. Eur J Nucl Med Mol Imaging. 2022. PMID: 35556158 Free PMC article.
Prostate cancer--chemoprevention.
Schröder FH, van Weerden WM. Schröder FH, et al. Among authors: van weerden wm. Eur J Cancer. 2009 Sep;45 Suppl 1:355-9. doi: 10.1016/S0959-8049(09)70050-4. Eur J Cancer. 2009. PMID: 19775632 Review. No abstract available.
Darolutamide added to docetaxel augments antitumor effect in models of prostate cancer through cell cycle arrest at the G1-S transition.
Buck SAJ, Van Hemelryk A, de Ridder C, Stuurman D, Erkens-Schulze S, Van 't Geloof S, Teubel WJ, Koolen SLW, Martens-Uzunova ES, van Royen ME, de Wit R, Mathijssen RHJ, van Weerden WM. Buck SAJ, et al. Among authors: van weerden wm. Mol Cancer Ther. 2023 Nov 30. doi: 10.1158/1535-7163.MCT-23-0420. Online ahead of print. Mol Cancer Ther. 2023. PMID: 38030379
86 results